Saculinggan, Glenn Marie Q.
HRN: 22-97-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFUROXIME 1.5GM (VIAL)
04/20/2024
04/20/2024
IV
1.5 G
Prior To OR
For Thyroidectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes